Amyotrophic lateral sclerosis: moving towards a new classification system

被引:283
作者
Al-Chalabi, Ammar [1 ]
Hardiman, Orla [2 ]
Kiernan, Matthew C. [3 ,4 ]
Chio, Adriano [5 ]
Rix-Brooks, Benjamin [6 ,7 ]
van den Berg, Leonard H. [8 ]
机构
[1] Kings Coll London, Dept Basic & Clin Neurosci, Maurice Wohl Clin Neurosci Inst, London, England
[2] Trinity Coll Dublin, Acad Unit Neurol, Inst Biomed Sci, Dublin, Ireland
[3] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia
[4] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[5] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy
[6] Carolinas Healthcare Syst, Neurosci Inst, Dept Neurol, Carolinas Neuromuscular ALS MDA Ctr,Carolinas Med, Charlotte, NC USA
[7] Univ N Carolina, Sch Med, Charlotte Campus, Charlotte, NC USA
[8] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands
基金
爱尔兰科学基金会; 英国医学研究理事会; 英国经济与社会研究理事会;
关键词
MOTOR-NEURON DISEASE; EL ESCORIAL CRITERIA; PROGRESSIVE MUSCULAR-ATROPHY; GENOME-WIDE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; NATURAL-HISTORY; AWAJI CRITERIA; ADULT-ONSET; FLAIL ARM; ELECTRODIAGNOSTIC CRITERIA;
D O I
10.1016/S1474-4422(16)30199-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sderosis is a progressive adult-onset neurodegenerative disease that primarily affects upper and lower motor neurons, but also frontotemporal and other regions of the brain. The extent to which each neuronal population is affected varies between individuals. The subsequent patterns of disease progression form the basis of diagnostic criteria and phenotypic classification systems, with considerable overlap in the clinical terms used. This overlap can lead to confusion between diagnosis and phenotype. Formal classification systems such as the El Escorial criteria and the International Classification of Diseases are systematic approaches but they omit features that are important in clinical management, such as rate of progression, genetic basis, or functional effect. Therefore, many neurologists use informal classification approaches that might not be systematic, and could include, for example, anatomical descriptions such as flail-arm syndrome. A new strategy is needed to combine the benefits of a systematic approach to classification with the rich and varied phenotypic descriptions used in clinical practice.
引用
收藏
页码:1182 / 1194
页数:13
相关论文
共 125 条
  • [1] ALS drug development: Reflections from the past and a way forward
    Aggarwal, Swati
    Cudkowicz, Merit
    [J]. NEUROTHERAPEUTICS, 2008, 5 (04) : 516 - 527
  • [2] The El Escorial criteria: Strengths and weaknesses
    Agosta, Federica
    Al-Chalabi, Ammar
    Filippi, Massimo
    Hardiman, Orla
    Kaji, Ryuji
    Meininger, Vincent
    Nakano, Imaharu
    Shaw, Pamela
    Shefner, Jeremy
    van den Berg, Leonard H.
    Ludolph, Albert
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2015, 16 (1-2) : 1 - 7
  • [3] Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
    AI-Chalabi, Ammar
    Calvo, Andrea
    Chio, Adriano
    Colville, Shuna
    Ellis, Cathy M.
    Hardiman, Oda
    Heverin, Mark
    Howard, Robin S.
    Huisman, Mark H. B.
    Keren, Noa
    Leigh, P. Nigel
    Mazzini, Letizia
    Mora, Gabriele
    Orrell, Richard W.
    Rooney, James
    Scott, Kirsten M.
    Scotton, William J.
    Seelen, Meinie
    Shaw, Christopher E.
    Sidle, Katie S.
    Swingler, Robert
    Tsuda, Miho
    Veldink, Jan H.
    Visser, Anne E.
    van den Berg, Leonard H.
    Pearce, Neil
    [J]. LANCET NEUROLOGY, 2014, 13 (11) : 1108 - 1113
  • [4] An estimate of amyotrophic lateral sclerosis heritability using twin data
    Al-Chalabi, A.
    Fang, F.
    Hanby, M. F.
    Leigh, P. N.
    Shaw, C. E.
    Ye, W.
    Rijsdijk, F.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (12) : 1324 - 1326
  • [5] The genetics and neuropathology of amyotrophic lateral sclerosis
    Al-Chalabi, Ammar
    Jones, Ashley
    Troakes, Claire
    King, Andrew
    Al-Sarraj, Safa
    van den Berg, Leonard H.
    [J]. ACTA NEUROPATHOLOGICA, 2012, 124 (03) : 339 - 352
  • [6] Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease
    Al-Chalabi, Ammar
    Lewis, Cathryn M.
    [J]. HUMAN HEREDITY, 2011, 71 (04) : 281 - 288
  • [7] Diagnostic yield and cost-effectiveness of investigations in patients presenting with isolated lower motor neuron signs
    Alanazy, Mohammed H.
    White, Chris
    Korngut, Lawrence
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (5-6) : 414 - 419
  • [8] EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force
    Andersen, Peter M.
    Abrahams, Sharon
    Borasio, Gian D.
    de Carvalho, Mamede
    Chio, Adriano
    Van Damme, Philip
    Hardiman, Orla
    Kollewe, Katja
    Morrison, Karen E.
    Petri, Susanne
    Pradat, Pierre-Francois
    Silani, Vincenzo
    Tomik, Barbara
    Wasner, Maria
    Weber, Markus
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (03) : 360 - E24
  • [9] Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
    Andersen, Peter M.
    Al-Chalabi, Ammar
    [J]. NATURE REVIEWS NEUROLOGY, 2011, 7 (11) : 603 - 615
  • [10] Aran F.A., 1850, Archives generales de medicine, V24, P172